| Angeline L Brechlin, APN | |
|
1415 E State St, Rockford, IL 61104-2333 | |
| (815) 489-4376 | |
| Not Available |
| Full Name | Angeline L Brechlin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 22 Years |
| Location | 1415 E State St, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689774531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 209004688 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockford Psychiatric Medical Services Sc | 6901089515 | 53 |
News Archive
Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from diabetic macular edema, one of the major causes of adult vision loss and an important complication of the growing epidemic of diabetes.
Over the past 20 years, many studies have investigated the effects of acute aerobic exercise on cognitive performance. In recent years, meta-analyses of data from these previous research studies have demonstrated that these a single bout of moderate aerobic exercise temporarily improves cognitive performance.
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
Ketamine is commonly used in emergency medicine as an anesthetic drug. Later it was discovered to have rapid-acting antidepressant effects, but the mechanisms by which ketamine alleviates depression are still unknown.
› Verified 5 days ago
| Entity Name | Rockford Psychiatric Medical Services Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821391442 PECOS PAC ID: 6901089515 Enrollment ID: O20110318000777 |
News Archive
Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from diabetic macular edema, one of the major causes of adult vision loss and an important complication of the growing epidemic of diabetes.
Over the past 20 years, many studies have investigated the effects of acute aerobic exercise on cognitive performance. In recent years, meta-analyses of data from these previous research studies have demonstrated that these a single bout of moderate aerobic exercise temporarily improves cognitive performance.
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
Ketamine is commonly used in emergency medicine as an anesthetic drug. Later it was discovered to have rapid-acting antidepressant effects, but the mechanisms by which ketamine alleviates depression are still unknown.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angeline L Brechlin, APN Po Box 1567, Rockford, IL 61110-0067 Ph: () - | Angeline L Brechlin, APN 1415 E State St, Rockford, IL 61104-2333 Ph: (815) 489-4376 |
News Archive
Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from diabetic macular edema, one of the major causes of adult vision loss and an important complication of the growing epidemic of diabetes.
Over the past 20 years, many studies have investigated the effects of acute aerobic exercise on cognitive performance. In recent years, meta-analyses of data from these previous research studies have demonstrated that these a single bout of moderate aerobic exercise temporarily improves cognitive performance.
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
Ketamine is commonly used in emergency medicine as an anesthetic drug. Later it was discovered to have rapid-acting antidepressant effects, but the mechanisms by which ketamine alleviates depression are still unknown.
› Verified 5 days ago
Sheila Yvette Standfield, ACNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Catherine A Rogers, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1401 E State St, Rockford, IL 61104 Phone: 815-489-4891 Fax: 815-967-5312 | |
Cindy L Fearn, A.P.N. Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 324 Roxbury Rd, Rockford, IL 61107 Phone: 815-398-9491 Fax: 815-381-7498 | |
Dauphne Sims, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2222 E State St, Suite 209, Rockford, IL 61104 Phone: 815-988-8500 Fax: 815-977-5956 | |
April Faas, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-886-2000 Fax: 815-227-2370 | |
Ashley Seyfert, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 535 Roxbury Rd, Rockford, IL 61107 Phone: 815-387-1717 Fax: 815-387-1716 | |
Catherine A Gentz, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1401 E State St, Rockford, IL 61104 Phone: 815-961-2460 |